Global Spine Biologics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Spine Biologics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 101

Published Date: 26 Jan 2021

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Spine Biologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Spine Biologics size is estimated to be USD 2698.2 million in 2026 from USD 2365 million in 2020, with a change XX% between 2020 and 2021. The global Spine Biologics market size is expected to grow at a CAGR of 3.3% for the next five years.

Market segmentation
Spine Biologics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
BMAC (Bone Marrow Aspirate Concentrate)

Market segment by Application, can be divided into
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion
Others

Market segment by players, this report covers
Medtronic
Depuy Synthes
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Spine Biologics
1.2 Classification of Spine Biologics by Type
1.2.1 Overview: Global Spine Biologics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Spine Biologics Revenue Market Share by Type in 2020
1.2.3 Bone Graft
1.2.4 Bone Graft Substitute
1.2.5 Platelet Rich Plasma (PRP)
1.2.6 BMAC (Bone Marrow Aspirate Concentrate)
1.3 Global Spine Biologics Market by Application
1.3.1 Overview: Global Spine Biologics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Anterior Cervical Discectomy and Fusion
1.3.3 Posterior Lumbar Interbody Fusion
1.3.4 Others
1.4 Global Spine Biologics Market Size & Forecast
1.5 Global Spine Biologics Market Size and Forecast by Region
1.5.1 Global Spine Biologics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Spine Biologics Market Size by Region, (2016-2021)
1.5.3 North America Spine Biologics Market Size and Prospect (2016-2026)
1.5.4 Europe Spine Biologics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Spine Biologics Market Size and Prospect (2016-2026)
1.5.6 South America Spine Biologics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Spine Biologics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Spine Biologics Market Drivers
1.6.2 Spine Biologics Market Restraints
1.6.3 Spine Biologics Trends Analysis

2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Spine Biologics Product and Solutions
2.1.4 Medtronic Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Medtronic Recent Developments and Future Plans
2.2 Depuy Synthes
2.2.1 Depuy Synthes Details
2.2.2 Depuy Synthes Major Business
2.2.3 Depuy Synthes Spine Biologics Product and Solutions
2.2.4 Depuy Synthes Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Depuy Synthes Recent Developments and Future Plans
2.3 Stryker Corporation
2.3.1 Stryker Corporation Details
2.3.2 Stryker Corporation Major Business
2.3.3 Stryker Corporation Spine Biologics Product and Solutions
2.3.4 Stryker Corporation Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Stryker Corporation Recent Developments and Future Plans
2.4 Nuvasive
2.4.1 Nuvasive Details
2.4.2 Nuvasive Major Business
2.4.3 Nuvasive Spine Biologics Product and Solutions
2.4.4 Nuvasive Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Nuvasive Recent Developments and Future Plans
2.5 Zimmer Biomet
2.5.1 Zimmer Biomet Details
2.5.2 Zimmer Biomet Major Business
2.5.3 Zimmer Biomet Spine Biologics Product and Solutions
2.5.4 Zimmer Biomet Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Zimmer Biomet Recent Developments and Future Plans
2.6 Orthofix International
2.6.1 Orthofix International Details
2.6.2 Orthofix International Major Business
2.6.3 Orthofix International Spine Biologics Product and Solutions
2.6.4 Orthofix International Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Orthofix International Recent Developments and Future Plans
2.7 Globus Medical
2.7.1 Globus Medical Details
2.7.2 Globus Medical Major Business
2.7.3 Globus Medical Spine Biologics Product and Solutions
2.7.4 Globus Medical Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Globus Medical Recent Developments and Future Plans
2.8 alphatec spine
2.8.1 alphatec spine Details
2.8.2 alphatec spine Major Business
2.8.3 alphatec spine Spine Biologics Product and Solutions
2.8.4 alphatec spine Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 alphatec spine Recent Developments and Future Plans
2.9 K2M
2.9.1 K2M Details
2.9.2 K2M Major Business
2.9.3 K2M Spine Biologics Product and Solutions
2.9.4 K2M Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 K2M Recent Developments and Future Plans
2.10 Exactech
2.10.1 Exactech Details
2.10.2 Exactech Major Business
2.10.3 Exactech Spine Biologics Product and Solutions
2.10.4 Exactech Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Exactech Recent Developments and Future Plans
2.11 Wright Medical Technology
2.11.1 Wright Medical Technology Details
2.11.2 Wright Medical Technology Major Business
2.11.3 Wright Medical Technology Spine Biologics Product and Solutions
2.11.4 Wright Medical Technology Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Wright Medical Technology Recent Developments and Future Plans
2.12 X-Spine
2.12.1 X-Spine Details
2.12.2 X-Spine Major Business
2.12.3 X-Spine Spine Biologics Product and Solutions
2.12.4 X-Spine Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 X-Spine Recent Developments and Future Plans
2.13 Nutech
2.13.1 Nutech Details
2.13.2 Nutech Major Business
2.13.3 Nutech Spine Biologics Product and Solutions
2.13.4 Nutech Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Nutech Recent Developments and Future Plans
2.14 Arthrex
2.14.1 Arthrex Details
2.14.2 Arthrex Major Business
2.14.3 Arthrex Spine Biologics Product and Solutions
2.14.4 Arthrex Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Arthrex Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Spine Biologics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Spine Biologics Players Market Share
3.2.2 Top 10 Spine Biologics Players Market Share
3.2.3 Market Competition Trend
3.3 Spine Biologics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Spine Biologics Revenue and Market Share by Type (2016-2021)
4.2 Global Spine Biologics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global Spine Biologics Revenue Market Share by Application (2016-2021)
5.2 Spine Biologics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America Spine Biologics Revenue by Type (2016-2026)
6.2 North America Spine Biologics Revenue by Application (2016-2026)
6.3 North America Spine Biologics Market Size by Country
6.3.1 North America Spine Biologics Revenue by Country (2016-2026)
6.3.2 United States Spine Biologics Market Size and Forecast (2016-2026)
6.3.3 Canada Spine Biologics Market Size and Forecast (2016-2026)
6.3.4 Mexico Spine Biologics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe Spine Biologics Revenue by Type (2016-2026)
7.2 Europe Spine Biologics Revenue by Application (2016-2026)
7.3 Europe Spine Biologics Market Size by Country
7.3.1 Europe Spine Biologics Revenue by Country (2016-2026)
7.3.2 Germany Spine Biologics Market Size and Forecast (2016-2026)
7.3.3 France Spine Biologics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Spine Biologics Market Size and Forecast (2016-2026)
7.3.5 Russia Spine Biologics Market Size and Forecast (2016-2026)
7.3.6 Italy Spine Biologics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Spine Biologics Revenue by Type (2016-2026)
8.2 Asia-Pacific Spine Biologics Revenue by Application (2016-2026)
8.3 Asia-Pacific Spine Biologics Market Size by Region
8.3.1 Asia-Pacific Spine Biologics Revenue by Region (2016-2026)
8.3.2 China Spine Biologics Market Size and Forecast (2016-2026)
8.3.3 Japan Spine Biologics Market Size and Forecast (2016-2026)
8.3.4 South Korea Spine Biologics Market Size and Forecast (2016-2026)
8.3.5 India Spine Biologics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Spine Biologics Market Size and Forecast (2016-2026)
8.3.7 Australia Spine Biologics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America Spine Biologics Revenue by Type (2016-2026)
9.2 South America Spine Biologics Revenue by Application (2016-2026)
9.3 South America Spine Biologics Market Size by Country
9.3.1 South America Spine Biologics Revenue by Country (2016-2026)
9.3.2 Brazil Spine Biologics Market Size and Forecast (2016-2026)
9.3.3 Argentina Spine Biologics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Spine Biologics Revenue by Type (2016-2026)
10.2 Middle East & Africa Spine Biologics Revenue by Application (2016-2026)
10.3 Middle East & Africa Spine Biologics Market Size by Country
10.3.1 Middle East & Africa Spine Biologics Revenue by Country (2016-2026)
10.3.2 Turkey Spine Biologics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Spine Biologics Market Size and Forecast (2016-2026)
10.3.4 UAE Spine Biologics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Spine Biologics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Spine Biologics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Spine Biologics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Spine Biologics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Spine Biologics Revenue Market Share by Region (2021-2026)
Table 6. Medtronic Corporate Information, Head Office, and Major Competitors
Table 7. Medtronic Major Business
Table 8. Medtronic Spine Biologics Product and Solutions
Table 9. Medtronic Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Depuy Synthes Corporate Information, Head Office, and Major Competitors
Table 11. Depuy Synthes Major Business
Table 12. Depuy Synthes Spine Biologics Product and Solutions
Table 13. Depuy Synthes Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Stryker Corporation Corporate Information, Head Office, and Major Competitors
Table 15. Stryker Corporation Major Business
Table 16. Stryker Corporation Spine Biologics Product and Solutions
Table 17. Stryker Corporation Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Nuvasive Corporate Information, Head Office, and Major Competitors
Table 19. Nuvasive Major Business
Table 20. Nuvasive Spine Biologics Product and Solutions
Table 21. Nuvasive Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Zimmer Biomet Corporate Information, Head Office, and Major Competitors
Table 23. Zimmer Biomet Major Business
Table 24. Zimmer Biomet Spine Biologics Product and Solutions
Table 25. Zimmer Biomet Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Orthofix International Corporate Information, Head Office, and Major Competitors
Table 27. Orthofix International Major Business
Table 28. Orthofix International Spine Biologics Product and Solutions
Table 29. Orthofix International Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Globus Medical Corporate Information, Head Office, and Major Competitors
Table 31. Globus Medical Major Business
Table 32. Globus Medical Spine Biologics Product and Solutions
Table 33. Globus Medical Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. alphatec spine Corporate Information, Head Office, and Major Competitors
Table 35. alphatec spine Major Business
Table 36. alphatec spine Spine Biologics Product and Solutions
Table 37. alphatec spine Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. K2M Corporate Information, Head Office, and Major Competitors
Table 39. K2M Major Business
Table 40. K2M Spine Biologics Product and Solutions
Table 41. K2M Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Exactech Corporate Information, Head Office, and Major Competitors
Table 43. Exactech Major Business
Table 44. Exactech Spine Biologics Product and Solutions
Table 45. Exactech Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Wright Medical Technology Corporate Information, Head Office, and Major Competitors
Table 47. Wright Medical Technology Major Business
Table 48. Wright Medical Technology Spine Biologics Product and Solutions
Table 49. Wright Medical Technology Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. X-Spine Corporate Information, Head Office, and Major Competitors
Table 51. X-Spine Major Business
Table 52. X-Spine Spine Biologics Product and Solutions
Table 53. X-Spine Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Nutech Corporate Information, Head Office, and Major Competitors
Table 55. Nutech Major Business
Table 56. Nutech Spine Biologics Product and Solutions
Table 57. Nutech Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Arthrex Corporate Information, Head Office, and Major Competitors
Table 59. Arthrex Major Business
Table 60. Arthrex Spine Biologics Product and Solutions
Table 61. Arthrex Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Spine Biologics Revenue (USD Million) by Players (2019-2021)
Table 63. Global Spine Biologics Revenue Share by Players (2019-2021)
Table 64. Breakdown of Spine Biologics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Spine Biologics Players Head Office, Products and Services Provided
Table 66. Spine Biologics Mergers & Acquisitions in the Past Five Years
Table 67. Spine Biologics New Entrants and Expansion Plans
Table 68. Global Spine Biologics Revenue (USD Million) by Type (2016-2021)
Table 69. Global Spine Biologics Revenue Share by Type (2016-2021)
Table 70. Global Spine Biologics Revenue Forecast by Type (2021-2026)
Table 71. Global Spine Biologics Revenue by Application (2016-2021)
Table 72. Global Spine Biologics Revenue Forecast by Application (2021-2026)
Table 73. North America Spine Biologics Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Spine Biologics Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Spine Biologics Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Spine Biologics Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Spine Biologics Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Spine Biologics Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Spine Biologics Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Spine Biologics Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Spine Biologics Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Spine Biologics Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Spine Biologics Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Spine Biologics Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Spine Biologics Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Spine Biologics Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Spine Biologics Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Spine Biologics Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Spine Biologics Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Spine Biologics Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Spine Biologics Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Spine Biologics Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Spine Biologics Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Spine Biologics Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Spine Biologics Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Spine Biologics Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Spine Biologics Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Spine Biologics Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Spine Biologics Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Spine Biologics Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Spine Biologics Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Spine Biologics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Spine Biologics Picture
Figure 2. Global Spine Biologics Revenue Market Share by Type in 2020
Figure 3. Bone Graft
Figure 4. Bone Graft Substitute
Figure 5. Platelet Rich Plasma (PRP)
Figure 6. BMAC (Bone Marrow Aspirate Concentrate)
Figure 7. Spine Biologics Revenue Market Share by Application in 2020
Figure 8. Anterior Cervical Discectomy and Fusion Picture
Figure 9. Posterior Lumbar Interbody Fusion Picture
Figure 10. Others Picture
Figure 11. Global Spine Biologics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Spine Biologics Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Spine Biologics Revenue Market Share by Region (2016-2026)
Figure 14. Global Spine Biologics Revenue Market Share by Region in 2020
Figure 15. North America Spine Biologics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Spine Biologics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Spine Biologics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Spine Biologics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Spine Biologics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Spine Biologics Market Drivers
Figure 21. Spine Biologics Market Restraints
Figure 22. Spine Biologics Market Trends
Figure 23. Medtronic Recent Developments and Future Plans
Figure 24. Depuy Synthes Recent Developments and Future Plans
Figure 25. Stryker Corporation Recent Developments and Future Plans
Figure 26. Nuvasive Recent Developments and Future Plans
Figure 27. Zimmer Biomet Recent Developments and Future Plans
Figure 28. Orthofix International Recent Developments and Future Plans
Figure 29. Globus Medical Recent Developments and Future Plans
Figure 30. alphatec spine Recent Developments and Future Plans
Figure 31. K2M Recent Developments and Future Plans
Figure 32. Exactech Recent Developments and Future Plans
Figure 33. Wright Medical Technology Recent Developments and Future Plans
Figure 34. X-Spine Recent Developments and Future Plans
Figure 35. Nutech Recent Developments and Future Plans
Figure 36. Arthrex Recent Developments and Future Plans
Figure 37. Global Spine Biologics Revenue Share by Players in 2020
Figure 38. Spine Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Spine Biologics Revenue Market Share in 2020
Figure 40. Global Top 10 Players Spine Biologics Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Spine Biologics Revenue Share by Type in 2020
Figure 43. Global Spine Biologics Market Share Forecast by Type (2021-2026)
Figure 44. Global Spine Biologics Revenue Share by Application in 2020
Figure 45. Global Spine Biologics Market Share Forecast by Application (2021-2026)
Figure 46. North America Spine Biologics Sales Market Share by Type (2016-2026)
Figure 47. North America Spine Biologics Sales Market Share by Application (2016-2026)
Figure 48. North America Spine Biologics Revenue Market Share by Country (2016-2026)
Figure 49. United States Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Spine Biologics Sales Market Share by Type (2016-2026)
Figure 53. Europe Spine Biologics Sales Market Share by Application (2016-2026)
Figure 54. Europe Spine Biologics Revenue Market Share by Country (2016-2026)
Figure 55. Germany Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Spine Biologics Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Spine Biologics Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Spine Biologics Revenue Market Share by Region (2016-2026)
Figure 63. China Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Spine Biologics Sales Market Share by Type (2016-2026)
Figure 70. South America Spine Biologics Sales Market Share by Application (2016-2026)
Figure 71. South America Spine Biologics Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Spine Biologics Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Spine Biologics Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Spine Biologics Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Medtronic
Depuy Synthes
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Spine Biologics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Spine Biologics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 101

Published Date: 26 Jan 2021

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Spine Biologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Spine Biologics size is estimated to be USD 2698.2 million in 2026 from USD 2365 million in 2020, with a change XX% between 2020 and 2021. The global Spine Biologics market size is expected to grow at a CAGR of 3.3% for the next five years.

Market segmentation
Spine Biologics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
BMAC (Bone Marrow Aspirate Concentrate)

Market segment by Application, can be divided into
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion
Others

Market segment by players, this report covers
Medtronic
Depuy Synthes
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Spine Biologics
1.2 Classification of Spine Biologics by Type
1.2.1 Overview: Global Spine Biologics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Spine Biologics Revenue Market Share by Type in 2020
1.2.3 Bone Graft
1.2.4 Bone Graft Substitute
1.2.5 Platelet Rich Plasma (PRP)
1.2.6 BMAC (Bone Marrow Aspirate Concentrate)
1.3 Global Spine Biologics Market by Application
1.3.1 Overview: Global Spine Biologics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Anterior Cervical Discectomy and Fusion
1.3.3 Posterior Lumbar Interbody Fusion
1.3.4 Others
1.4 Global Spine Biologics Market Size & Forecast
1.5 Global Spine Biologics Market Size and Forecast by Region
1.5.1 Global Spine Biologics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Spine Biologics Market Size by Region, (2016-2021)
1.5.3 North America Spine Biologics Market Size and Prospect (2016-2026)
1.5.4 Europe Spine Biologics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Spine Biologics Market Size and Prospect (2016-2026)
1.5.6 South America Spine Biologics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Spine Biologics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Spine Biologics Market Drivers
1.6.2 Spine Biologics Market Restraints
1.6.3 Spine Biologics Trends Analysis

2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Spine Biologics Product and Solutions
2.1.4 Medtronic Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Medtronic Recent Developments and Future Plans
2.2 Depuy Synthes
2.2.1 Depuy Synthes Details
2.2.2 Depuy Synthes Major Business
2.2.3 Depuy Synthes Spine Biologics Product and Solutions
2.2.4 Depuy Synthes Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Depuy Synthes Recent Developments and Future Plans
2.3 Stryker Corporation
2.3.1 Stryker Corporation Details
2.3.2 Stryker Corporation Major Business
2.3.3 Stryker Corporation Spine Biologics Product and Solutions
2.3.4 Stryker Corporation Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Stryker Corporation Recent Developments and Future Plans
2.4 Nuvasive
2.4.1 Nuvasive Details
2.4.2 Nuvasive Major Business
2.4.3 Nuvasive Spine Biologics Product and Solutions
2.4.4 Nuvasive Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Nuvasive Recent Developments and Future Plans
2.5 Zimmer Biomet
2.5.1 Zimmer Biomet Details
2.5.2 Zimmer Biomet Major Business
2.5.3 Zimmer Biomet Spine Biologics Product and Solutions
2.5.4 Zimmer Biomet Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Zimmer Biomet Recent Developments and Future Plans
2.6 Orthofix International
2.6.1 Orthofix International Details
2.6.2 Orthofix International Major Business
2.6.3 Orthofix International Spine Biologics Product and Solutions
2.6.4 Orthofix International Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Orthofix International Recent Developments and Future Plans
2.7 Globus Medical
2.7.1 Globus Medical Details
2.7.2 Globus Medical Major Business
2.7.3 Globus Medical Spine Biologics Product and Solutions
2.7.4 Globus Medical Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Globus Medical Recent Developments and Future Plans
2.8 alphatec spine
2.8.1 alphatec spine Details
2.8.2 alphatec spine Major Business
2.8.3 alphatec spine Spine Biologics Product and Solutions
2.8.4 alphatec spine Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 alphatec spine Recent Developments and Future Plans
2.9 K2M
2.9.1 K2M Details
2.9.2 K2M Major Business
2.9.3 K2M Spine Biologics Product and Solutions
2.9.4 K2M Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 K2M Recent Developments and Future Plans
2.10 Exactech
2.10.1 Exactech Details
2.10.2 Exactech Major Business
2.10.3 Exactech Spine Biologics Product and Solutions
2.10.4 Exactech Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Exactech Recent Developments and Future Plans
2.11 Wright Medical Technology
2.11.1 Wright Medical Technology Details
2.11.2 Wright Medical Technology Major Business
2.11.3 Wright Medical Technology Spine Biologics Product and Solutions
2.11.4 Wright Medical Technology Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Wright Medical Technology Recent Developments and Future Plans
2.12 X-Spine
2.12.1 X-Spine Details
2.12.2 X-Spine Major Business
2.12.3 X-Spine Spine Biologics Product and Solutions
2.12.4 X-Spine Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 X-Spine Recent Developments and Future Plans
2.13 Nutech
2.13.1 Nutech Details
2.13.2 Nutech Major Business
2.13.3 Nutech Spine Biologics Product and Solutions
2.13.4 Nutech Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Nutech Recent Developments and Future Plans
2.14 Arthrex
2.14.1 Arthrex Details
2.14.2 Arthrex Major Business
2.14.3 Arthrex Spine Biologics Product and Solutions
2.14.4 Arthrex Spine Biologics Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Arthrex Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Spine Biologics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Spine Biologics Players Market Share
3.2.2 Top 10 Spine Biologics Players Market Share
3.2.3 Market Competition Trend
3.3 Spine Biologics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Spine Biologics Revenue and Market Share by Type (2016-2021)
4.2 Global Spine Biologics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global Spine Biologics Revenue Market Share by Application (2016-2021)
5.2 Spine Biologics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America Spine Biologics Revenue by Type (2016-2026)
6.2 North America Spine Biologics Revenue by Application (2016-2026)
6.3 North America Spine Biologics Market Size by Country
6.3.1 North America Spine Biologics Revenue by Country (2016-2026)
6.3.2 United States Spine Biologics Market Size and Forecast (2016-2026)
6.3.3 Canada Spine Biologics Market Size and Forecast (2016-2026)
6.3.4 Mexico Spine Biologics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe Spine Biologics Revenue by Type (2016-2026)
7.2 Europe Spine Biologics Revenue by Application (2016-2026)
7.3 Europe Spine Biologics Market Size by Country
7.3.1 Europe Spine Biologics Revenue by Country (2016-2026)
7.3.2 Germany Spine Biologics Market Size and Forecast (2016-2026)
7.3.3 France Spine Biologics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Spine Biologics Market Size and Forecast (2016-2026)
7.3.5 Russia Spine Biologics Market Size and Forecast (2016-2026)
7.3.6 Italy Spine Biologics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Spine Biologics Revenue by Type (2016-2026)
8.2 Asia-Pacific Spine Biologics Revenue by Application (2016-2026)
8.3 Asia-Pacific Spine Biologics Market Size by Region
8.3.1 Asia-Pacific Spine Biologics Revenue by Region (2016-2026)
8.3.2 China Spine Biologics Market Size and Forecast (2016-2026)
8.3.3 Japan Spine Biologics Market Size and Forecast (2016-2026)
8.3.4 South Korea Spine Biologics Market Size and Forecast (2016-2026)
8.3.5 India Spine Biologics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Spine Biologics Market Size and Forecast (2016-2026)
8.3.7 Australia Spine Biologics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America Spine Biologics Revenue by Type (2016-2026)
9.2 South America Spine Biologics Revenue by Application (2016-2026)
9.3 South America Spine Biologics Market Size by Country
9.3.1 South America Spine Biologics Revenue by Country (2016-2026)
9.3.2 Brazil Spine Biologics Market Size and Forecast (2016-2026)
9.3.3 Argentina Spine Biologics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Spine Biologics Revenue by Type (2016-2026)
10.2 Middle East & Africa Spine Biologics Revenue by Application (2016-2026)
10.3 Middle East & Africa Spine Biologics Market Size by Country
10.3.1 Middle East & Africa Spine Biologics Revenue by Country (2016-2026)
10.3.2 Turkey Spine Biologics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Spine Biologics Market Size and Forecast (2016-2026)
10.3.4 UAE Spine Biologics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Spine Biologics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Spine Biologics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Spine Biologics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Spine Biologics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Spine Biologics Revenue Market Share by Region (2021-2026)
Table 6. Medtronic Corporate Information, Head Office, and Major Competitors
Table 7. Medtronic Major Business
Table 8. Medtronic Spine Biologics Product and Solutions
Table 9. Medtronic Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Depuy Synthes Corporate Information, Head Office, and Major Competitors
Table 11. Depuy Synthes Major Business
Table 12. Depuy Synthes Spine Biologics Product and Solutions
Table 13. Depuy Synthes Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Stryker Corporation Corporate Information, Head Office, and Major Competitors
Table 15. Stryker Corporation Major Business
Table 16. Stryker Corporation Spine Biologics Product and Solutions
Table 17. Stryker Corporation Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Nuvasive Corporate Information, Head Office, and Major Competitors
Table 19. Nuvasive Major Business
Table 20. Nuvasive Spine Biologics Product and Solutions
Table 21. Nuvasive Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Zimmer Biomet Corporate Information, Head Office, and Major Competitors
Table 23. Zimmer Biomet Major Business
Table 24. Zimmer Biomet Spine Biologics Product and Solutions
Table 25. Zimmer Biomet Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Orthofix International Corporate Information, Head Office, and Major Competitors
Table 27. Orthofix International Major Business
Table 28. Orthofix International Spine Biologics Product and Solutions
Table 29. Orthofix International Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Globus Medical Corporate Information, Head Office, and Major Competitors
Table 31. Globus Medical Major Business
Table 32. Globus Medical Spine Biologics Product and Solutions
Table 33. Globus Medical Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. alphatec spine Corporate Information, Head Office, and Major Competitors
Table 35. alphatec spine Major Business
Table 36. alphatec spine Spine Biologics Product and Solutions
Table 37. alphatec spine Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. K2M Corporate Information, Head Office, and Major Competitors
Table 39. K2M Major Business
Table 40. K2M Spine Biologics Product and Solutions
Table 41. K2M Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Exactech Corporate Information, Head Office, and Major Competitors
Table 43. Exactech Major Business
Table 44. Exactech Spine Biologics Product and Solutions
Table 45. Exactech Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Wright Medical Technology Corporate Information, Head Office, and Major Competitors
Table 47. Wright Medical Technology Major Business
Table 48. Wright Medical Technology Spine Biologics Product and Solutions
Table 49. Wright Medical Technology Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. X-Spine Corporate Information, Head Office, and Major Competitors
Table 51. X-Spine Major Business
Table 52. X-Spine Spine Biologics Product and Solutions
Table 53. X-Spine Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Nutech Corporate Information, Head Office, and Major Competitors
Table 55. Nutech Major Business
Table 56. Nutech Spine Biologics Product and Solutions
Table 57. Nutech Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Arthrex Corporate Information, Head Office, and Major Competitors
Table 59. Arthrex Major Business
Table 60. Arthrex Spine Biologics Product and Solutions
Table 61. Arthrex Spine Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Spine Biologics Revenue (USD Million) by Players (2019-2021)
Table 63. Global Spine Biologics Revenue Share by Players (2019-2021)
Table 64. Breakdown of Spine Biologics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Spine Biologics Players Head Office, Products and Services Provided
Table 66. Spine Biologics Mergers & Acquisitions in the Past Five Years
Table 67. Spine Biologics New Entrants and Expansion Plans
Table 68. Global Spine Biologics Revenue (USD Million) by Type (2016-2021)
Table 69. Global Spine Biologics Revenue Share by Type (2016-2021)
Table 70. Global Spine Biologics Revenue Forecast by Type (2021-2026)
Table 71. Global Spine Biologics Revenue by Application (2016-2021)
Table 72. Global Spine Biologics Revenue Forecast by Application (2021-2026)
Table 73. North America Spine Biologics Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Spine Biologics Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Spine Biologics Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Spine Biologics Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Spine Biologics Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Spine Biologics Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Spine Biologics Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Spine Biologics Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Spine Biologics Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Spine Biologics Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Spine Biologics Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Spine Biologics Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Spine Biologics Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Spine Biologics Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Spine Biologics Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Spine Biologics Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Spine Biologics Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Spine Biologics Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Spine Biologics Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Spine Biologics Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Spine Biologics Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Spine Biologics Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Spine Biologics Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Spine Biologics Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Spine Biologics Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Spine Biologics Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Spine Biologics Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Spine Biologics Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Spine Biologics Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Spine Biologics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Spine Biologics Picture
Figure 2. Global Spine Biologics Revenue Market Share by Type in 2020
Figure 3. Bone Graft
Figure 4. Bone Graft Substitute
Figure 5. Platelet Rich Plasma (PRP)
Figure 6. BMAC (Bone Marrow Aspirate Concentrate)
Figure 7. Spine Biologics Revenue Market Share by Application in 2020
Figure 8. Anterior Cervical Discectomy and Fusion Picture
Figure 9. Posterior Lumbar Interbody Fusion Picture
Figure 10. Others Picture
Figure 11. Global Spine Biologics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Spine Biologics Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Spine Biologics Revenue Market Share by Region (2016-2026)
Figure 14. Global Spine Biologics Revenue Market Share by Region in 2020
Figure 15. North America Spine Biologics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Spine Biologics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Spine Biologics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Spine Biologics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Spine Biologics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Spine Biologics Market Drivers
Figure 21. Spine Biologics Market Restraints
Figure 22. Spine Biologics Market Trends
Figure 23. Medtronic Recent Developments and Future Plans
Figure 24. Depuy Synthes Recent Developments and Future Plans
Figure 25. Stryker Corporation Recent Developments and Future Plans
Figure 26. Nuvasive Recent Developments and Future Plans
Figure 27. Zimmer Biomet Recent Developments and Future Plans
Figure 28. Orthofix International Recent Developments and Future Plans
Figure 29. Globus Medical Recent Developments and Future Plans
Figure 30. alphatec spine Recent Developments and Future Plans
Figure 31. K2M Recent Developments and Future Plans
Figure 32. Exactech Recent Developments and Future Plans
Figure 33. Wright Medical Technology Recent Developments and Future Plans
Figure 34. X-Spine Recent Developments and Future Plans
Figure 35. Nutech Recent Developments and Future Plans
Figure 36. Arthrex Recent Developments and Future Plans
Figure 37. Global Spine Biologics Revenue Share by Players in 2020
Figure 38. Spine Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Spine Biologics Revenue Market Share in 2020
Figure 40. Global Top 10 Players Spine Biologics Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Spine Biologics Revenue Share by Type in 2020
Figure 43. Global Spine Biologics Market Share Forecast by Type (2021-2026)
Figure 44. Global Spine Biologics Revenue Share by Application in 2020
Figure 45. Global Spine Biologics Market Share Forecast by Application (2021-2026)
Figure 46. North America Spine Biologics Sales Market Share by Type (2016-2026)
Figure 47. North America Spine Biologics Sales Market Share by Application (2016-2026)
Figure 48. North America Spine Biologics Revenue Market Share by Country (2016-2026)
Figure 49. United States Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Spine Biologics Sales Market Share by Type (2016-2026)
Figure 53. Europe Spine Biologics Sales Market Share by Application (2016-2026)
Figure 54. Europe Spine Biologics Revenue Market Share by Country (2016-2026)
Figure 55. Germany Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Spine Biologics Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Spine Biologics Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Spine Biologics Revenue Market Share by Region (2016-2026)
Figure 63. China Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Spine Biologics Sales Market Share by Type (2016-2026)
Figure 70. South America Spine Biologics Sales Market Share by Application (2016-2026)
Figure 71. South America Spine Biologics Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Spine Biologics Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Spine Biologics Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Spine Biologics Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Spine Biologics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Medtronic
Depuy Synthes
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now